Results 11 to 20 of about 10,859 (138)

Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report

open access: yesBrazilian Journal of Medical and Biological Research, 2021
Inv(16)(p13.1q22) in acute myeloid leukemia (AML) is a common chromosomal abnormality. It leads to the core-binding factor ß-subunit (CBFβ)/smooth muscle myosin heavy chain 11 (MYH11) fusion gene.
Wenyi Zhang   +5 more
doaj   +1 more source

An Myh11 single lysine deletion causes aortic dissection by reducing aortic structural integrity and contractility

open access: yesScientific Reports, 2022
Pathogenic variants in myosin heavy chain (Myh11) cause familial thoracic aortic aneurysms and dissections (FTAAD). However, the underlying pathological mechanisms remain unclear because of a lack of animal models.
Keita Negishi   +16 more
doaj   +1 more source

CBFB-MYH11 Fusion Sequesters RUNX1 in Cytoplasm to Prevent DNMT3A Recruitment to Target Genes in AML

open access: yesFrontiers in Cell and Developmental Biology, 2021
A growing number of human diseases have been found to be associated with aberrant DNA methylation, including cancer. Mutations targeting genes encoding DNA methyltransferase (DNMT), TET family of DNA demethylases, and isocitrate dehydrogenase (IDH1, IDH2)
Peng Liu   +10 more
doaj   +1 more source

Genetic approaches to identify pathological limitations in aortic smooth muscle contraction. [PDF]

open access: yesPLoS ONE, 2018
Aortic smooth muscle contains limiting amounts of myosin light chain kinase (MLCK) for myosin regulatory light chain (RLC) phosphorylation and contraction that predisposes to thoracic aortic disease in humans containing heterozygous loss-of-function ...
Jian Huang   +5 more
doaj   +1 more source

Analytical study of RUNX1-RUNXT1, PML-RARA, CBFB-MYH11, BCR-ABL1p210, and KMT2-MLLT3 in Mexican children with acute myeloid leukemia: A multicenter study of the Mexican interinstitutional group for the identification of the causes of childhood leukemia (MIGICCL)

open access: yesFrontiers in Pediatrics, 2022
BackgroundThe distribution of RUNX1-RUNXT1, PML-RARA, CBFB-MYH11, BCR-ABL1p210, and KMT2A-MLLT3 in the pediatric population with acute myeloid leukemia (AML) in many countries of Latin America is largely unknown.
Omar Sepúlveda-Robles   +32 more
doaj   +1 more source

Extracellular matrix remodeling associated with bleomycin-induced lung injury supports pericyte-to-myofibroblast transition

open access: yesMatrix Biology Plus, 2021
Of the many origins of pulmonary myofibroblasts, microvascular pericytes are a known source. Prior literature has established the ability of pericytes to transition into myofibroblasts, but provide limited insight into molecular cues that drive this ...
Riley T. Hannan   +5 more
doaj   +1 more source

Generating endogenous Myh11-driven Cre mice for sex-independent gene deletion in smooth muscle cells

open access: yesJCI Insight, 2023
Specific and efficient smooth muscle cell–targeted (SMC-targeted) gene deletion is typically achieved by pairing SMMHC-CreERT2-Tg mice with mice carrying the loxP-flanked gene.
Yang Zhao   +11 more
doaj   +1 more source

Genome-wide binding of transcription factors in inv(16) acute myeloid leukemia

open access: yesGenomics Data, 2014
The inv(16) translocation is associated with 5% of AML cases and gives rise to expression of the oncofusion protein CBFβ-MYH11. Although different molecular mechanisms for the oncogenic activity of this fusion protein have been proposed these were mostly
A. Mandoli, K. Prange, J.H.A. Martens
doaj   +1 more source

A novel cryptic CBFB-MYH11 gene fusion present at birth leading to acute myeloid leukemia and allowing molecular monitoring for minimal residual disease

open access: yesHuman Pathology: Case Reports, 2018
Acute myeloid leukemia (AML) with the inv(16)/t(16;16) karyotype is associated with a favourable prognosis, showing longer periods of complete remission and high overall survival rates.
P.J. Poddighe   +12 more
doaj   +1 more source

Detection of del(16q) using the CBFB-MYH11 translocation dual fusion probe

open access: yesHematology/Oncology and Stem Cell Therapy, 2021
Del(16q) is an uncommon cytogenetic abnormality that can occur in different types of myeloid neoplasms. A small number of cases with del(16q) have been reported.
Doaa F. Temerik   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy